Total Funding
76
11
Total FundingSeed raised
Growth Score 76 in past quarter
-9 pts
Heat Score 11 in past quarter
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
54311
Rarity is a biotechnology company that offers genetic treatments for immune diseases.
- Paul Ayoub: CEO & Co-Founder
- Katelyn Masiuk: Co-Founder & Chief Scientific OfficerPast Role: UCLA, Clinical Project Lead - ADA-SCID gene therapy
About the Company
Rarity PBC is a biotechnology company that offers genetic treatments for immune diseases.